John T Schiller
Overview
Explore the profile of John T Schiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
8986
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torgbor C, Sohn H, Dizon B, Mutic E, George R, Kwak K, et al.
Proc Natl Acad Sci U S A
. 2025 Mar;
122(10):e2414514122.
PMID: 40030014
B cell responses to membrane-presented antigens appear to be strongly favored over soluble antigens in vivo suggesting that vaccines that mimic membrane-presented antigens may be highly efficacious. We recently demonstrated...
2.
Sierra M, Carvajal L, Dull P, Herrero R, Schussler J, Hildesheim A, et al.
Vaccine
. 2025 Feb;
50:126841.
PMID: 39961279
Background: New approaches to control HPV infections and prevent progression to cervical precancer are needed. We investigate the probability of viral clearance and progression to cervical precancer in women infected...
3.
Porras C, Romero B, Kemp T, Fantin R, Herrero R, Hildesheim A, et al.
J Natl Cancer Inst Monogr
. 2024 Nov;
2024(67):329-336.
PMID: 39529529
Background: The Costa Rica HPV Vaccine Trial provided initial evidence that 1 dose of the bivalent human papillomavirus (HPV) vaccine induces stabilizing antibody levels that may provide extended protection against...
4.
Dull P, Achilles S, Ahmed R, Barnabas R, Campos N, Chirgwin K, et al.
Vaccine
. 2024 Jul;
42(25):126100.
PMID: 39004526
Cervical cancer is a major cause of morbidity and mortality globally with a disproportionate impact on women in low- and middle-income countries. In 2021, the World Health Organization (WHO) called...
5.
Shing J, Porras C, Pinheiro M, Herrero R, Hildesheim A, Liu D, et al.
NPJ Vaccines
. 2024 Jun;
9(1):101.
PMID: 38851816
The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be affected by variant-level...
6.
Kamuyu G, da Silva F, Tenet V, Schussler J, Godi A, Herrero R, et al.
Nat Commun
. 2024 Feb;
15(1):1608.
PMID: 38383518
Human Papillomavirus (HPV) type variants have been classified into lineages and sublineages based upon their whole genome sequence. Here we have examined the specificity of antibodies generated following natural infection...
7.
Schiller J, Kreimer A
Lancet Oncol
. 2023 Nov;
24(12):1288-1289.
PMID: 37949087
No abstract available.
8.
Fowler A, Van Rompay K, Sampson M, Leo J, Watanabe J, Usachenko J, et al.
NPJ Vaccines
. 2023 Sep;
8(1):142.
PMID: 37770440
Elevated low-density lipoprotein cholesterol (LDL-C) is an important risk factor in the development of atherosclerotic cardiovascular disease (ASCVD). Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9), a negative regulator of...
9.
Fowler A, Van Rompay K, Sampson M, Leo J, Watanabe J, Usachenko J, et al.
bioRxiv
. 2023 Jun;
PMID: 37292981
Elevated low-density lipoprotein cholesterol (LDL-C) is an important risk factor in the development of atherosclerotic cardiovascular disease (ASCVD). Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9), a negative regulator of...
10.
Shiels M, Lipkowitz S, Campos N, Schiffman M, Schiller J, Freedman N, et al.
Cancer Discov
. 2023 Apr;
13(5):1084-1099.
PMID: 37067240
Significance: We reviewed opportunities to prevent, detect, and treat common cancers, and show that to achieve the Moonshot goal, progress against lung, colorectal, and breast cancer deaths needs to be...